阵发性睡眠性血红蛋白尿11年后发生慢性粒细胞白血病1例报告
Paroxysmal nocturnal hemoglobinuria transforming to chronic myeloid leukemia: a case report
摘要
1病历资料
患者男,63岁,2002年因“间断性茶色尿3个月”为主诉收入院。血常规:白细胞(WBC)3.8×10^9L,血红蛋白(Hh)72g/L,血小板(PLT)21×10^9/L,网织红细胞(Ret)0.6%。骨髓形态学:骨髓增生活跃,红系增生减低(10%)。Coombs试验阴性,Ham试验阳性,蔗糖溶血试验阳性,尿Rous试验阳性。
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2016年第1期82-83,共2页
Chinese Journal of Practical Internal Medicine
基金
国家自然科学基金(81170489)
江苏省自然科学基金(BK20141254)
参考文献11
-
1Wang H, Chuhjo T, Yasue S, et al. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome [J]. Blood, 2002, 100 (12): 3897-3902.
-
2Sugimori C, Chuhjo T, Feng Xj et al. Minor population of CD55- CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia[J]. Blood, 2006, 107(4): 1308-1314.
-
3Ishiyama K, Chuhjo T, Wang H, et al. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells[J]. Blood, 2003, 102(4): 1211-1216.
-
4Sugimori C, Mochizuki K, Oj Z, et al. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure[J]. BrJ Haematol, 2009, 147(1): 102-112.
-
5Ariel I, Weiler-Ravell D, Stalnikowicz R. Preleukemia in acute lymphoblastic leukemia [J].Acta Haematol, 1981, 66(1): 50-52.
-
6Katahira J, Aoyama M, Oshimi K, et al. Paroxysmal nocturnal hemoglobinuria terminating in TdT-positive acute leukemia [J]. Am J Hematol, 1983, 14(1): 79-87.
-
7Saad P, Sameer S, Ruth S, et al. Acute Lymphoblastic Leukemic Transformation in a Patient With Chronic Idiopathic Myeloiabrosis and Paroxysmal Nocturnal Hemoglobinuria [J]. Arch Pathol Lab Med, 2005, 129(1): 96-99.
-
8Isoda A, Ogawa Y, Matsumoto M, et al. Coexistence of paroxysmal nocturnal hemoglobinuria (PNH) and acute lymphoblastic leukemia (ALL): is PNH a prodrome of ALL? [J]. Leuk Res, 2009, 33(3):e3-eS.
-
9Mortazavi Y, Tooze JA, Gordon-Smith EC, et al. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/paroxysmal nocturnal hemoglobinuria during evolution to clonal disease[J]. Blood, 2000, 95(2):646-650.
-
10Tanaka H, Imamura N, Oguma N, et al. Acute myelogenous leukemia with PlG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome[J]. IntJ Hematol, 2001, 73(2): 206-212.
二级参考文献15
-
1齐静,彭晖,顾振纶,梁中琴,杨纯正.伊马替尼耐药的K562细胞系的建立及其生物学特性研究[J].中华血液学杂志,2004,25(6):337-341. 被引量:20
-
2Wang Y, Waldron TR, Dhaka A, et al. The Ras effector RIN1 derectly competes with RAF and is regulated by 14-3-3 proteins [J]. Mol Cell Biol, 2002, 22(3): 916-926.
-
3Bliss JM, Venkatesh B, ColicelliJ. The RIIq family of Ras effectors[J]. Methods Enzymol, 2006, 407: 335-344.
-
4Hu H, Bliss JM, Wang Y~ et al. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration[J]. Curr Biol, 2005, 15(9): 815-823.
-
5Cao X, Tanis KOa Koleske AJ, et al. Enhancemnt ofABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms [J]. J Biol Chem, 2008, 283 (46): 31401-31407.
-
6Younos IH, Dafferner AJ, Gulen D, et al. Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking [J]. Int Immunopharmacol, 2012, 13(3): 245-256.
-
7Chmine K, Nagai T, Tarumoto T, et al. Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22/ SR[J]. Stem Cells, 2003, 21(3): 315-321.
-
8Thai M, Ting PYj McLaughlin J, et al. ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1 [J]. Leukemia, 2011, 25(2): 290-300.
-
9Tala I~ Chen R, Hu T, et al. Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression[J]. Leukemia, 2013, 27(5): 1080-1089.
-
10Patel H, Marley SB, Gordon MY. Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2[J]. Genes Chromosomes Cancer, 2006, 45(12): 1121-1129.
共引文献4
-
1胡晶,冯敏,刘毅,刘张玲,李会,黄峥兰,冯文莉.吲哚美辛对慢性粒细胞白血病急变期CD34^+细胞的影响研究[J].解放军医学杂志,2016,41(6):472-478. 被引量:5
-
2刘鑫,崔淼淼,付珮一,黄凌,徐方明.同源建模构建ABLSH3突变体及其与RIN1蛋白结合能力的分析[J].药物生物技术,2016,23(4):345-348. 被引量:2
-
3汪玉芳,柯善栋,柯金勇,王宏志.慢性粒细胞白血病患者使用伊马替尼早期治疗前后CFLI-1表达水平变化及其临床意义[J].贵州医药,2018,42(5):560-562. 被引量:2
-
4南虎松,金春姬.三七皂苷R1对CD34^+人急性髓系白血病细胞的增殖抑制作用及对线粒体相关通路的影响[J].中国临床药理学杂志,2018,34(15):1869-1871. 被引量:5
-
1苏磊,刘云松.病例6-1 重症中暑并多脏器功能衰竭死亡1例(病历摘要)[J].解放军医学杂志,2007,32(10):1096-1096.
-
2马宏杰,段泽晔.原发性骨髓纤维化1例[J].包头医学院学报,2002,18(1):78-79.
-
3董斌,马晓伟.伴有茶色尿的糖尿病酮症酸中毒1例分析[J].中华糖尿病杂志(1006-6187),2005,13(1):22-22. 被引量:3
-
4钱泓洁,汤正义.糖尿病合并心力衰竭的发病与相关发病机制[J].诊断学理论与实践,2012,11(1):84-87. 被引量:9
-
5尤红,刘小玉,刘德俊,刘春梅,刘艳菊,贾品.生物反馈治疗在抑郁症患者中的应用[J].中国健康心理学杂志,2010,18(9):1027-1029. 被引量:11
-
6林东红.护理干预在2型糖尿病中的应用[J].中国中医药咨讯,2010(36):205-205. 被引量:1
-
7梁资繁,冷玲娟.巯甲丙脯酸、硝酸甘油、强心剂、利尿剂联合治疗中、重度心衰84例[J].医学临床研究,2006,23(8):1338-1339. 被引量:2
-
8罗麟洁,范世明,唐凤鸣,张健.氟哌噻吨美利曲辛治疗COPD合并焦虑/抑郁患者的临床研究[J].云南医药,2016,37(2):146-150. 被引量:4
-
9刘岐焕,程范军.COP方案治疗难治性纯红再障1例报告[J].世界今日医学杂志,2001,2(5):427-427.
-
10王二慧,刘秀兰.血栓性血小板减少性紫癜一例[J].内蒙古医学杂志,2004,36(12):1027-1027.